| Status | Topic selection |
| Technology type | Medicine |
| Decision | Not selected |
| Further information | Decision makers have concluded that the clear rationale to not evaluate this product is due to appropriate access to the medicine being provided by an existing NHSE clinical commissioning policy. Therefore, a NICE evaluation would not add any further value. |
| ID number | 12043 |
Project Team
| Project lead | Danielle Lees |
Email enquiries
- If you have any queries please email topic.selection@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 10 September 2024 | Topic selection |
| 20 June 2024 | Topic selection |
For further information on how we select topics for development, please see our page about topic selection